Inappropriate expression of NF-κB has been reported in certain human tumors, such as colorectal cancer, breast cancer, colon cancer, multiple myeloma, melanoma, prostate cancer, and Hodgkin's lymphoma [20–24]. Here, NFKB1 is linked to Hodgkins lymphoma.